Ron Balassanian, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech
    Topic:
    Patient education videos consultant
    Date added:
    04/10/2023
    Date updated:
    04/10/2023
    Relationship end date:
    12/20/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Cerus corp
    Topic:
    $150 stock
    Date added:
    04/10/2023
    Date updated:
    04/10/2023
Return to 2023 Summit on Cancer Health Disparities: Reframing and Addressing Barriers to Adoption of Precision Oncology